Literature DB >> 15732793

[Extramedullary plasmacytoma of the head and neck].

Oksana Korolkowa1, Ewa Osuch-Wójcikiewicz, Andrzej Deptała, Wael Suleiman.   

Abstract

The aim of this review was to present plasma cell neoplasms, their development, common features and classification. Extramedullary plasmacytoma (EMP) is a most often plasma cell neoplasm in the head and neck. 80-90% EMP cases concern to head and neck: 40% nasal cavity and paranasal sinuses, about 20% nasopharynx, 18% oropharynx. Tumour symptoms are similar like in other neoplasm. It is very important to remember about plasma cell neoplasm during differential diagnosis because of relatively common occurrence. Extramedullary plasmacytoma is radiosensitive neoplasm with good prognosis therefore radiation therapy is the method of choice.

Entities:  

Mesh:

Year:  2004        PMID: 15732793

Source DB:  PubMed          Journal:  Otolaryngol Pol        ISSN: 0030-6657


  5 in total

1.  [Problems breathing through the nose and diplopic images].

Authors:  H Rödig; O Guntinas-Lichius; T Bitter
Journal:  HNO       Date:  2016-03       Impact factor: 1.284

2.  Solitary plasmacytoma of the mandible - a rare entity.

Authors:  Rajendra Baad; Sonam C Kapse; Nanita Rathod; Kishor Sonawane; Sanjay Gangadhar Thete; M Naveen Kumar
Journal:  J Int Oral Health       Date:  2013-06-23

3.  Freiburg neuropathology case conference: a patient with chronic nasal obstruction.

Authors:  C A Taschner; V A Frey; C Offergeld; H Urbach; C J Maurer; G Kayser
Journal:  Clin Neuroradiol       Date:  2015-02-04       Impact factor: 3.649

4.  Extramedullary plasmacytoma of the cricoid cartilage progressing to multiple myeloma: A case report.

Authors:  Min Wang; Jintao DU; Jian Zou; Shixi Liu
Journal:  Oncol Lett       Date:  2015-02-05       Impact factor: 2.967

5.  Extramedullary plasmacytoma of the nasal inferior turbinate: a case report.

Authors:  Yan Liu; Xiaopei Yuan; Xiaohong Peng; Zhiming Xing; Lisheng Yu
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.